What is a stock summary page? Click here for an overview.
Business Description
Pulmatrix Inc
NAICS : 325412
SIC : 2834
ISIN : US74584P1030
Description
Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 449.25 | |||||
| Equity-to-Asset | 0.95 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | -8.44 | |||||
| Beneish M-Score | -1.19 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -39 | |||||
| 3-Year EBITDA Growth Rate | 16 | |||||
| 3-Year EPS without NRI Growth Rate | 17.8 | |||||
| 3-Year FCF Growth Rate | 19.9 | |||||
| 3-Year Book Growth Rate | -27.3 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 27.75 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.13 | |||||
| 9-Day RSI | 45.1 | |||||
| 14-Day RSI | 47.6 | |||||
| 3-1 Month Momentum % | 48.67 | |||||
| 6-1 Month Momentum % | 307.31 | |||||
| 12-1 Month Momentum % | 443.9 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 19.4 | |||||
| Quick Ratio | 19.4 | |||||
| Cash Ratio | 18.27 | |||||
| Days Sales Outstanding | 21.87 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -26.5 | |||||
| Shareholder Yield % | -11.33 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -74.14 | |||||
| Net Margin % | -96.51 | |||||
| FCF Margin % | -118.58 | |||||
| ROE % | -59.51 | |||||
| ROA % | -37.6 | |||||
| ROIC % | -83.59 | |||||
| 3-Year ROIIC % | -147.42 | |||||
| ROC (Joel Greenblatt) % | -104.76 | |||||
| ROCE % | -32.57 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.75 | |||||
| PB Ratio | 2.5 | |||||
| Price-to-Tangible-Book | 2.49 | |||||
| EV-to-EBIT | -2.29 | |||||
| EV-to-EBITDA | -2.51 | |||||
| EV-to-Revenue | 1.7 | |||||
| EV-to-FCF | -1.43 | |||||
| Price-to-GF-Value | 1.87 | |||||
| Price-to-Net-Current-Asset-Value | 2.51 | |||||
| Price-to-Net-Cash | 2.67 | |||||
| Earnings Yield (Greenblatt) % | -43.67 | |||||
| FCF Yield % | -43.49 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:PULM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pulmatrix Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 10.005 | ||
| EPS (TTM) ($) | -2.64 | ||
| Beta | 2 | ||
| 3-Year Sharpe Ratio | 0.34 | ||
| 3-Year Sortino Ratio | 1.43 | ||
| Volatility % | 200.19 | ||
| 14-Day RSI | 47.6 | ||
| 14-Day ATR ($) | 0.648636 | ||
| 20-Day SMA ($) | 7.72545 | ||
| 12-1 Month Momentum % | 443.9 | ||
| 52-Week Range ($) | 1.5601 - 10.4 | ||
| Shares Outstanding (Mil) | 3.65 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pulmatrix Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pulmatrix Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Pulmatrix Inc Frequently Asked Questions
What is Pulmatrix Inc(PULM)'s stock price today?
The current price of PULM is $7.46. The 52 week high of PULM is $10.40 and 52 week low is $1.56.
When is next earnings date of Pulmatrix Inc(PULM)?
The next earnings date of Pulmatrix Inc(PULM) is 2025-03-28 Est..
Does Pulmatrix Inc(PULM) pay dividends? If so, how much?
Pulmatrix Inc(PULM) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers